Daniel M Hallow

Title: The Innovations of Daniel M Hallow

Introduction

Daniel M Hallow is an accomplished inventor based in Bishop, Georgia. He has made significant contributions to the field of cannabinoid research and antiviral treatments. With a total of two patents to his name, Hallow's work showcases his dedication to advancing scientific knowledge and practical applications.

Latest Patents

Hallow's latest patents include "Cannabidiol compositions having modified cannabinoid profiles." This patent relates to the preparation of a highly pure cannabidiol compound through a novel synthesis route. The process involves an acid-catalyzed reaction of a di-halo olivetol with menthadienol, followed by two crystallization steps. The resulting cannabidiol compound is produced in high yield and stereospecificity, exhibiting exceedingly low levels of Δ-9-tetrahydrocannabinol both at the time of preparation and after storage. Another notable patent is for "Hepatitis C virus inhibitors," which details methods for making asunaprevir, a useful treatment for Hepatitis C virus (HCV) infection, along with its intermediates.

Career Highlights

Throughout his career, Hallow has worked with prominent companies such as Purisys, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.

Collaborations

Hallow has collaborated with notable coworkers, including Jun He and Mark C Dobish. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Daniel M Hallow's contributions to cannabinoid research and antiviral treatments highlight his role as a significant inventor in the field. His patents reflect a commitment to scientific advancement and practical solutions for health-related challenges.